Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma

Author:

Bisogno Gianni,Ferrari Andrea,Prete Arcangelo,Messina Chiara,Basso Eleonora,Cecchetto Giovanni,Indolfi Paolo,Scarzello Giovanni,D’Angelo Paolo,Sio Luigi De,Cataldo Andrea Di,Carli Modesto

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. European Intergroup Studies (MMT4–89 and MMT4–91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors;Carli;J Clin Oncol,2004

2. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the Intergroup Rhabdomyosarcoma Study IV;Breneman;J Clin Oncol,2003

3. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma;Weigel;J Pediatr Hematol Oncol,2001

4. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med 1999;341(16):165–173.

5. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma;Carli;J Clin Oncol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3